CRIS Current Research Information System

DE PONTI, FABRIZIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.741
EU - Europa 7.905
AS - Asia 4.026
AF - Africa 622
Continente sconosciuto - Info sul continente non disponibili 35
SA - Sud America 33
OC - Oceania 23
Totale 23.385
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.701
GB - Regno Unito 2.222
IT - Italia 1.884
CN - Cina 1.353
DE - Germania 1.012
SG - Singapore 1.008
VN - Vietnam 933
SE - Svezia 756
UA - Ucraina 531
IN - India 441
IE - Irlanda 319
FR - Francia 276
RU - Federazione Russa 272
TG - Togo 216
ZA - Sudafrica 164
CI - Costa d'Avorio 148
EE - Estonia 143
JO - Giordania 78
HR - Croazia 72
BG - Bulgaria 71
CH - Svizzera 68
BE - Belgio 60
FI - Finlandia 53
JP - Giappone 42
NG - Nigeria 41
CA - Canada 35
NL - Olanda 35
SC - Seychelles 35
EU - Europa 34
ID - Indonesia 29
HK - Hong Kong 25
AT - Austria 24
GR - Grecia 24
PL - Polonia 22
AU - Australia 17
IR - Iran 15
TW - Taiwan 15
ES - Italia 14
CZ - Repubblica Ceca 13
RO - Romania 13
UZ - Uzbekistan 13
BR - Brasile 12
CL - Cile 10
PH - Filippine 10
KR - Corea 8
LB - Libano 8
PT - Portogallo 8
TR - Turchia 8
IL - Israele 7
SA - Arabia Saudita 7
TH - Thailandia 7
NZ - Nuova Zelanda 6
MA - Marocco 5
CO - Colombia 4
DZ - Algeria 4
EG - Egitto 4
KZ - Kazakistan 4
PE - Perù 4
BD - Bangladesh 3
DK - Danimarca 3
KE - Kenya 3
LT - Lituania 3
MX - Messico 3
AM - Armenia 2
AR - Argentina 2
BA - Bosnia-Erzegovina 2
LK - Sri Lanka 2
MY - Malesia 2
RS - Serbia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AL - Albania 1
AZ - Azerbaigian 1
CY - Cipro 1
HU - Ungheria 1
JM - Giamaica 1
KG - Kirghizistan 1
KH - Cambogia 1
PA - Panama 1
PK - Pakistan 1
SM - San Marino 1
TN - Tunisia 1
UG - Uganda 1
VE - Venezuela 1
Totale 23.385
Salva come PNG Salva come JPEG
Città #
Southend 2.005
Fairfield 1.279
Chandler 939
Singapore 895
Ashburn 720
Dong Ket 656
Wilmington 619
Woodbridge 574
Seattle 555
Ann Arbor 543
Princeton 493
Houston 481
Santa Clara 480
Cambridge 427
Bologna 331
Dublin 311
Boardman 281
Jacksonville 278
Lomé 216
Westminster 187
Padova 173
Nanjing 169
Berlin 149
Abidjan 148
Redmond 115
Milan 111
Saint Petersburg 102
Beijing 92
San Diego 90
Jinan 89
Rome 87
Amman 78
New York 76
Medford 72
Shenyang 72
Bremen 71
Sofia 71
Turin 71
Nanchang 61
Hebei 60
Brussels 58
Falls Church 58
Mülheim 57
Bern 52
Changsha 52
Florence 48
Helsinki 46
Los Angeles 46
Shanghai 45
Jiaxing 44
Verona 44
Dearborn 43
Guangzhou 43
Tianjin 43
Zhengzhou 41
Abeokuta 38
Des Moines 38
Mahé 31
Redwood City 30
Jakarta 27
Norwalk 27
Olalla 27
Ningbo 26
Hangzhou 24
London 24
Modena 24
Bühl 23
Toronto 23
Biella 22
Tokyo 22
Taizhou 19
Chicago 18
Phoenix 18
Vienna 18
Fuzhou 17
Haikou 16
Kunming 16
Lanzhou 16
Shenzhen 16
Wuhan 16
Messina 15
Naples 15
Pune 15
Taipei 15
Taiyuan 15
Wayne 15
San Venanzo 14
Boydton 13
Hong Kong 13
Chengdu 12
Harbin 12
Paris 12
Washington 12
Groningen 11
Ravenna 11
Costa Mesa 10
Mountain View 10
Andover 9
Brescia 9
Frankfurt am Main 9
Totale 15.770
Salva come PNG Salva come JPEG
Nome #
Interazioni tra sistema serotoninergico e mediatori dell'infiammazione nella fisiopatologia della sindrome dell'intestino irritabile 556
Torsadogenic risk of antipsychotics: combining adverse event reports with drug utilization data across Europe. 442
Data Mining Techniques in Pharmacovigilance: Analysis of the Publicly Accessible FDA Adverse Event Reporting System (AERS) 241
Adverse events with sacubitril/valsartan in the real world: emerging signals to target preventive strategies from the FDA adverse event reporting system 229
Escherichia coli Nissle 1917 restores epithelial permeability alterations induced by irritable bowel syndrome mediators 218
Adverse events with sodium-glucose co-transporter-2 inhibitors: A global analysis of international spontaneous reporting systems 209
Adherence to chronic cardiovascular therapies: persistence over the years and dose coverage 203
Appropriateness of Proton Pump Inhibitor (PPI) prescription in patients admitted to hospital: Attitudes of general practitioners and hospital physicians in Italy 190
Adverse cardiovascular events associated with triptans and ergotamines for treatment of migraine: Systematic review of observational studies 189
Diagnosis and therapy of irritable bowel syndrome 185
Adverse Events to Food Supplements Containing Red Yeast Rice: Comparative Analysis of FAERS and CAERS Reporting Systems 180
Elementi di Farmacologia: Compendio per l’esame. 177
Advancements in drug development for diarrhea-predominant irritable bowel syndrome 177
Anticancer drugs and cardiotoxicity: Insights and perspectives in the era of targeted therapy. 169
Adherence to chronic cardiovascular therapies: persistence over the years and dose coverage. 168
Antibacterial macrolides: a drug class with a complex pharmacological profile 164
Antipsychotics and Torsadogenic Risk: Signals Emerging from the US FDA Adverse Event Reporting System Database. 162
Biomarkers of Kidney Injury in Very-low-birth-weight Preterm Infants: Influence of Maternal and Neonatal Factors 161
Adverse events associated with the use of direct-acting oral anticoagulants in clinical practice: beyond bleeding complications 159
Prescriptions of antidepressants in primary care in Italy: pattern of use after admission of selective serotonin reuptake inhibitors for reimbursement 157
Colonic mucosal mediators from patients with irritable bowel syndrome excite enteric cholinergic motor neurons 157
Animal models of chemically induced intestinal inflammation: Predictivity and ethical issues 155
Antimicrobials and the Risk of Torsades de Pointes. The Contribution from Data Mining of the US FDA Adverse Event Reporting System 154
Farmacologia. Azioni e Reazioni dei farmaci. 153
Switching among Equivalents in Chronic Cardiovascular Therapies: 'Real World' Data from Italy 152
An update on the first decade of the European centralized procedure: how many innovative drugs? 149
Dipeptidyl peptidase-4 inhibitors and heart failure: Analysis of spontaneous reports submitted to the FDA Adverse Event Reporting System 149
Addition of dipeptidyl peptidase-4 inhibitors to sulphonylureas and risk of hypoglycaemia: systematic review and meta-analysis 148
beta3-adrenoceptors in the gut: evidence for a possible role in enteric neuroimmunomodulation 145
Academic output from EU-funded health research projects 141
Assessing liver injury associated with antimycotics: Concise literature review and clues from data mining of the FAERS database 140
Nerve fiber outgrowth is increased in the intestinal mucosa of patients with irritable bowel syndrome 140
Cardiovascular events in statin recipients: impact of adherence to treatment in a 3-year record linkage study 139
5-HT7 Receptors Modulate Peristalsis and Accommodation in the Guinea Pig Ileum 139
Aspetti clinici ed anticorpi anti-neurone nella malattia celiaca con disordini neurologici 139
Altered Serotonin Signaling and Extrinsic Sensory Neuron Activation in Irritable Bowel Syndrome 139
Clinically important drug-drug interactions in poly-treated elderly outpatients: A campaign to improve appropriateness in general practice 136
Therapeutic innovation in the European Union: analysis of the drugs approved by the EMEA between 1995 and 2003. 134
Intestinal serotonin release, sensory neuron activation, and abdominal pain in irritable bowel syndrome. 134
Multiple sclerosis as an adverse drug reaction: clues from the FDA Adverse Event Reporting System 134
Drug-induced renal injury in neonates: challenges in clinical practice and perspectives in drug development 133
Pattern of drug use among preterm neonates: Results from an Italian neonatal intensive care unit 133
Toxicities with Immune Checkpoint Inhibitors: Emerging Priorities From Disproportionality Analysis of the FDA Adverse Event Reporting System 133
Case Report. 131
Detection of D-penicillamine in skin lesions in a case of dermal elastosis after a previous long-term treatment for Wilson's disease 130
Severe quetiapine voluntary overdose successfully treated with a new hemoperfusion sorbent 130
Myocarditis and pericarditis after immunization: Gaining insights through the Vaccine Adverse Event Reporting System 130
Paraneoplastic Syndrome 129
Social and clinical descriptors of antipsychotic prescription 129
Hepatitis B vaccination and the putative risk of central demyelinating diseases - A systematic review and meta-analysis 129
Disproportionality signal of progressive multifocal leukoencephalopathy: monoclonal antibodies versus other immunosuppressants 128
Drug-induced Kounis syndrome: A matter of pharmacovigilance 128
Risk of hospitalization from drug-drug interactions in the Elderly: real-world evidence in a large administrative database 127
Drug-Induced Renal Damage in Preterm Neonates: State of the Art and Methods for Early Detection 126
Occurrence of Multiple Sclerosis After Drug Exposure: Insights From Evidence Mapping 126
Protection from DNBS-induced colitis by the tachykinin NK1 receptor antagonist SR140333 in rats 126
Pro-arrhythmic potential of oral antihistamines (H1): Combining adverse event reports with drug utilization data across Europe 126
Posterior Reversible Encephalopathy Syndrome Associated With Licorice Consumption: A Case Report in a 10-Year-Old Boy 125
Neuroplasticity of the enteric nervous system induced by inflammatory conditions in the gut 124
Targeting the arrhythmogenic substrate in atrial fibrillation: focus on structural remodeling 124
Effects of the non-peptidyl low molecular weight radical scavenger IAC in DNBS-induced colitis in rats. 124
hERG-related drug toxicity and models for predicting hERG liability and QT prolongation 123
The Contribution of National Spontaneous Reporting Systems to Detect Signals of Torsadogenicity: Issues Emerging from the ARITMO Project 123
La condivisione dei trattamenti farmacologici in psichiatria e la percezione degli effetti avversi ai farmaci antipisicotici da medico, paziente e familiare 122
Initial treatment of hypertension and adherence to therapy in general practice in Italy 120
Delayed gastric emptying in functional dyspepsia 119
Non-peptidyl low molecular weight radical scavenger IAC attenuates DSS-induced colitis in rats. 118
Pattern of NSAID use in the Italian general population: a questionnaire-based survey. 118
Use of phytoestrogens and effects perceived by postmenopausal women: result of a questionnaire-based survey 117
Inflammatory neuropathies of the enteric nervous system 116
Association between the use of proton pump inhibitors and cardiovascular events: A note of caution 116
Cardiovascular toxicity of anticancer-targeted therapy: emerging issues in the era of cardio-oncology. 115
Long-acting injectable antipsychotics: Six-month follow-up of new outpatient treatments in Bologna Community Mental Health Centres 115
Excipients in medicinal products used in gastroenterology as a possible cause of side effects. 113
Mesenchymal stromal cell-based therapy: Regulatory and translational aspects in gastroenterology 113
The association of pancreatitis with antidiabetic drug use: gaining insight through the FDA pharmacovigilance database. 113
Review article: clinical implications of enteric and central D2 receptor blockade by antidopaminergic gastrointestinal prokinetics 112
QT interval shortening in spontaneous reports submitted to the FDA: the need for consensus 112
The hERG K+ channel: target and antitarget strategies in drug development. 112
Stroke, Migraine and Triptans: From Bedside to Bench 112
Human papillomavirus vaccine and demyelinating diseases-A systematic review and meta-analysis 112
Enteric neuroplasticity evoked by inflammation 110
Advising Mothers on the Use of Medications during Breastfeeding : A Need for a Positive Attitude 110
Dapagliflozin and cardiovascular outcomes: anything else to DECLARE? 110
Role of drugs and devices in patients at risk of sudden cardiac death. 110
Gastro-intestinal problems and concomitant medication in NSAID users: additional findings from a questionnaire-based survey in Italy 109
Phytoestrogens in postmenopause: the state of the art from a chemical, pharmacological and regulatory perspective 108
Antimicrobial-induced torsades de pointes: towards risk stratification by data mining of the FDA Adverse Event Reporting System. 108
Recurrence of pericarditis after influenza vaccination: a case report and review of the literature 108
Effect of muscarinic receptor blockade on canine gastric tone and compliance in vivo 107
5-HT7 receptors are involved in the accommodation of the circular muscle during peristalsis in the guinea-pig ileum 104
Pharmacologic, pharmacokinetic, and pharmacogenomic aspects of functional gastrointestinal disorders 104
Gender- and age-related differences in muscular and nerve-mediated responses in human colon 103
Strategy for a genetic assessment of antipsychotic and antidepressant-related proarrhythmia. 103
Ceftolozane/tazobactam exposure in critically ill patients undergoing continuous renal replacement therapy: a PK/PD approach to tailor dosing 103
Serotonin receptor modulators 102
Macrolides and Torsadogenic Risk: Emerging Issues from the FDA Pharmacovigilance Database 101
Trends in antiarrhythmic drug use after marketing authorization of dronedarone: comparison between Emilia Romagna (Italy) and Sweden. 100
The beta3-adrenoceptor as a therapeutic target: current perspectives. 100
Cardiovascular events in statin recipients: a 3-year record-linkage study on prescription and hospital discharge databases 100
Totale 14.225
Salva come PNG Salva come JPEG
Categoria #
all - tutte 64.551
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 64.551
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.356 0 0 0 0 0 500 642 701 655 368 164 326
2020/20213.428 633 257 72 166 95 253 90 202 265 180 209 1.006
2021/20224.483 556 147 257 225 361 275 185 276 176 228 1.084 713
2022/20234.475 446 555 300 564 309 314 209 276 753 191 384 174
2023/20241.553 127 216 136 165 146 236 67 116 54 112 105 73
2024/20253.013 282 842 600 295 812 182 0 0 0 0 0 0
Totale 23.965